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Abstract
The opposition between polycomb repressive complexes (PRC) and BAF (mSWI/SNF) complexes 
plays critical roles in development and disease. Mutations in the genes encoding BAF subunits 
contribute to over 20% of human malignancy, yet the underlying mechanisms remain unclear 
owing largely to a lack of assays to assess BAF function in vivo. To address this, we have 
developed a widely applicable recruitment assay system and find that BAF opposes PRC by rapid, 
ATP-dependent eviction, leading to the formation of accessible chromatin. Reversing this process 
results in reassembly of facultative heterochromatin. Surprisingly, BAF-mediated PRC eviction 
occurs in the absence of PolII occupancy, transcription, and replication. Further, we find that 
tumor suppressor and oncogenic BAF complex mutations result in differential effects on PRC 
eviction. These studies define a mechanistic sequence underlying the resolution and formation of 
facultative heterochromatin and demonstrate that BAF opposes polycomb complexes on a minute-
by-minute basis to provide epigenetic plasticity.
INTRODUCTION
The portion of the genome available to regulatory mechanisms appears to reflect a balance 
between chromatin processes that favor accessibility and those that oppose it. This balance 
was first recognized in Drosophila, in which the trithorax group of genes was shown to favor 
activation of developmental genes, while polycomb genes were found to oppose activation1. 
The trithorax genes encode enzymes that produce the activating histone modification 
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H3K4me3 or the BAP (Brahma Associated Protein) ATP-dependent chromatin remodeling 
complex2–4. Genetically, trithorax proteins act in opposition to the polycomb genes, which 
encode the subunits of the Polycomb repressive complex 1 (PRC1) and 2 (PRC2). These 
complexes direct H2A ubiquitination and H3K27me3 modification, respectively, favoring 
inaccessible chromatin5. The presence of PRC1 and PRC2 is a mark of ‘facultative 
heterochromatin’, which is distinguished from constitutive heterochromatin at centromeres 
and other regions of the genome.
Genomic studies have revealed that the genes involved in this opposition are frequently 
mutated in human cancer. Subunits of the mammalian mSWI/SNF or BAF (for Brg/Brm 
associated factor) complexes are mutated in over 20% of all human cancers6,7 and a large 
number of human neurologic diseases8–11. These complexes promote accessibility at least in 
part by opposing the actions of polycomb complexes12,13. The MLL genes are catalytic 
subunits of the Compass complex and place the activation-associated H3K4me3 
modification14, and are mutated in a large number of somatic cancers4. The repressive PRC2 
subunit EZH2 is mutated or silenced in a number of leukemias and lymphomas15,16,17.
In mammals, BAF complexes are combinatorially assembled into 15-subunit assemblies 
encoded by 29 genes, giving rise to highly polymorphic complexes that can be exquisitely 
cell type-specific, such as the nBAF complex found only in post mitotic neurons18,19. The 
BAF subunit mutations in human cancer have a striking pattern of tissue specificity. For 
example, nearly 100% of cases of human synovial sarcoma are produced by the SS18–SSX 
(t(X;18) translocation, however the SS18 BAF subunit is rarely mutated in other cancers. 
Malignant rhabdoid tumors (MRTs) are uniformly produced by deletions or loss-of-function 
mutations in BAF47 (hSNF5), but this subunit is less frequently involved in other human 
cancers20. Present data indicate that the mechanisms of oncogenesis appear to relate to the 
ability of BAF complexes to oppose polycomb-mediated repression. In human MRTs, loss 
of BAF47 leads to polycomb-mediated repression of genes that suppress proliferation, such 
as INK4A21 and reexpression of BAF47 leads to removal of polycomb and loss of DNA 
methylation by an unknown mechanism(s) 22. While informative, long time courses of 
reexpression in these earlier experiments prevented direct mechanistic analysis and the 
removal of polycomb could have been due to differentiation, replication or other cell 
biologic actions. Nevertheless correlative studies suggested that BAF might evict polycomb 
at this locus. Conversely, in synovial sarcoma, the SS18-SSX oncogenic fusion protein, 
which is the product of the oncogenic allele dominantly assembles into BAF complexes, 
targeting them to silenced polycomb target genes, where it appears to remove polycomb23. 
However, it is not known if the BAF-Polycomb balance is achieved directly or indirectly, nor 
is there any knowledge of causal sequence of biochemical events that provide this critical 
balance.
The mechanism underlying BAF-Polycomb opposition has been difficult to study. This is 
because present in vitro approaches using nucleosomal templates are unable to mimic the 
effects of tissue-specific histone modifications, long-range interactions, topological features, 
and post-translational modifications of the proteins involved. To elucidate the mechanism, 
we developed a method to rapidly and reversibly recruit a chromatin regulator of interest to 
one allele of an endogenous gene and then measure and model the sequence of biochemical 
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events at this locus. We find that BAF complex recruitment evicts both PRC1 and PRC2 
within 5 minutes followed by the development of accessibility. The order of deletion and 
reappearance predicts that PRC1 activity precedes PRC2 activity. These studies reveal that, 
in contrast to expectations, BAF complexes opposes both PRC1 and PRC2 on a minute-by-
minute basis without need for replication, PolII occupancy, or transcription.
RESULTS
Development of an assay system to study the mechanism of BAF-Polycomb opposition
To study the opposition between BAF and polycomb at repressed facultative 
heterochromatin, we modified the endogenous Oct4 (Pou5f1). The Oct4 locus in MEFs is 
repressed by polycomb complexes24,25 and H3K9me326 and lacks BAF complex occupancy; 
by contrast, in pluripotent cells, the locus lacks Polycomb and instead has robust Brg1 
(Smarca4) binding over the proximal enhancer, which is essential for Oct regulation12,27–29 
(Supplementary Fig. 1a). To analyze the resolution of heterochromatin by BAF we 
developed the CiAO mouse (Chromatin Assay at and Indicator at Oct4) by modifying one 
Oct4 allele with two different arrays of transcription factor bindings sites upstream of the 
transcription initiation site30 (Fig. 1a, Supplementary Fig. 1b). In addition, GFP was inserted 
into the Oct4 allele allowing visualization of active cells, but inactivating one allele. The 
allele containing the insertions is regulated similarly, both qualitatively and quantitatively, to 
the unmodified allele and that histone modification are indistinguishable (Supplementary 
Fig. 1c, Fig. 1b). These observations indicate that local and long-range topologic features are 
not disturbed on the modified allele and that the insertion does not modify the pattern of 
histone modifications. The Oct4 allele containing the insertions is active in pluripotent cells 
and germ cells derived from the CIAO mouse, but intensely repressed in fibroblasts by 
polycomb group marks such as H3K27me3 as well as H3K9me3 (Fig. 1c). The Oct4 locus 
undergoes repression upon ES differentiation30, and in fibroblasts, the gene can only be 
activated after prolonged exposure to the core pluripotency factors 31.
This system provides a broadly applicable model for developmental chromatin regulation 
allowing the temporally precise addition of one specific factor within a context of normal 
chromatin. While signaling pathways such as the LIF-STAT3 pathway also induce chromatin 
changes, LIF responses are too diverse, involve too many chromatin regulators and too 
asynchronous to allow mechanistic interpretation12,32. We used the CIP (Chemical Inducer 
of Proximity), rapamycin, to induce proximity of proteins at the modified Oct4 allele by 
virtue of its ability to bind one protein tag (Frb) on one side and another tag (FKBP) on the 
other side of the molecule (Fig. 1a). Because rapamycin binding is diffusion-limited and the 
off rate is on the order of seconds, this approach does not produce a rigid topology, but 
rather a cloud of complexes 33,34. This is in contrast to direct fusions, which produce rigid 
conformations that can sterically restrict the activity of the recruited proteins. Thus, the 
recruited BAF complex is free to assume its normal mode of binding to the Oct4 locus. To 
induce proximity of the BAF complex, we chose to fuse the SS18 subunit to Frb because 
SS18 remains stably associated with the BAF complex to ≥ 5M urea and is also a dedicated 
subunit 23,35 (Fig. 1d). We confirmed proper complex assembly of the Frb-V5-tagged SS18 
subunit (Supplemental Fig. 1d), as well as Frb-V5-tagged BAF47 and BAF57 subunits 
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(Supplemental Fig. 1e). We fused FKBP to the DNA binding domain of the ZFHD1 zinc 
finger, to bind the ZFHD1 sites inserted ~250 bp upstream of the Oct4 promoter within a 
large repressed, H2Aub1, H3K27me3- and H3K9me3- decorated domain in fibroblasts 
(Supplemental Fig. 1b). We evaluated the feasibility and robustness of this system using 
three BAF complex subunit fusions and determined that within 24 hours, BAF complex 
recruitment was induced 40–60 fold over baseline levels and that the SS18 subunit-based 
recruitment was optimal (Fig. 1e, Supplemental Fig. 1f). This strategy is a chemical-genetic 
gain-of-function approach that only requires a few dozen binding events to induce 
recruitment to the single allele, thereby allowing the endogenous mTor (FRB) and FKBP12 
molecules to perform their normal functions30,33.
Remarkably, addition of 3.0 nM rapamycin recruited the entire 2 MDa BAF complex to the 
Oct4 locus with a lag time of only 2 minutes (t= 2.2<t<4.8 min, CI= 95%) and at levels 
similar to BAF peaks over the genome of ES cells (Supplemental Fig. 1g). To be certain that 
the complexes were fully assembled, we performed ChIP experiments using antibodies to 
V5 (to capture the Frb-V5-SS18 bearing complexes), as well as Brg1 and Baf155 and found 
that each was effectively recruited within 2–5 minutes (Fig. 1f, Supplemental Fig 1h, left 
and right). Importantly, the levels and extent of BAF binding by 3 nM rapamycin were 
similar to BAF peaks over the genome27. BAF complexes occupied a region of 
approximately 1200 bp, consistent with binding of a single 2MD complex6 (Fig. 1g). Based 
on published studies36, we calculate the fractional occupancy at about 20% and the dwell 
time <83 seconds indicating that the recruited complexes are maintained at this location in 
part by direct interactions with facultative heterochromatin. Thus, using this CIP system, 
BAF complexes can be recruited, at normal levels and dynamics within minutes.
Recruitment of BAF complexes results in rapid eviction of PRC complexes
Mutations of the Drosophila BAP (dSWI/SNF) ATPase, Brm, entirely suppresses the effects 
of PRC1 mutations on body plan morphogenesis, attesting to their functional 
dedication13,37,38. Importantly, BAF-PcG opposition has become increasingly recognized as 
an oncogenic mechanism in several human cancers 21,23,39. Thus we first measured the 
effect of BAF recruitment on PRC eviction (Fig. 2a). We find that recruitment of BAF leads 
to the removal of both the PRC2 complex (Ezh2) and the H3K27me3 mark within minutes 
(Fig. 2b, Supplementary Fig. 2a). We also tested the alternative possibility that BAF 
recruitment removes PRC2 complexes with subsequent loss of H3K27me3 by comparing the 
time-course of their removal after recruitment of the BAF complex. Unexpectedly, we found 
a full 10-minute lag between the removal of PRC2 (Ezh2) and the initial reduction of 
H3K27me3 (t(lag)= 9.22<t<11.41 min) (Fig. 2b). This lag-time is unlikely to reflect 
differences in antibody detection, since the modification is more abundant than the enzyme.
PRC2 works in synergy with PRC1 to repress genes2 and both PRC complexes and their 
associated histone marks and complexes are present at the repressed Oct4 gene of 
fibroblasts. In flies, PRC1 (the pc1 or CBX6 subunit) mutants are repressed effectively by 
mutations in the ATPase Brm13. Remarkably, PRC1 complexes disappeared from the 
repressed Oct4 locus with even faster kinetics compared to PRC2, as assayed by ChIP using 
an antibody to Ring1b (Fig. 2c). Eviction of PRC1 was paralleled by dissolution of the 
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H2Aub1 repressive mark (Fig. 2c). Decreased occupancy of the H2AK119ub mark preceded 
the decreased occupancy of the H3K27me3 mark (Fig. 2d, right).
These observations raised the question as to whether BAF recruitment-mediated PRC 
displacement was a result of increased rate of nucleosome or histone exchange, as previous 
studies have shown that BAF complexes can exchange nucleosomes in vitro; although this 
possibility has not been tested in vivo40,41. We found that within the first hour there was no 
detectable change in the levels of H3K9me3, the other prominent repressive mark at this 
locus, or total H3, or H2A.Z, suggesting that the removal of H3K27me3 resulting from BAF 
complex recruitment does not reflect a non-specific enhancement of nucleosomal turnover 
(Fig. 2d left, Supplementary Fig. 2b).
Because we unexpectedly could not detect H3 depletion after BAF complex recruitment, we 
developed another murine model system by double knock-in of the DNA-binding sites and 
GFP reporter, which we call CiAA (Chromatin indicator and Assay at Ascl1). Here we used 
the Ascl1 locus which encodes the neuronal pioneer factor Ascl1, which has both 
H3K27me3 and H3K4me3 over its regulatory regions and has a CpG island, often seen at 
PRC- marked sties 4238. Ascl1 promoter is occupied by polymerase and the promoter 
accessible (ENCODE data). Hence, Ascl1 in ES cells is quite different than Oct4 in 
fibroblasts and allowed us to test the robustness of our findings. Similar to Oct4 in MEFs, 
we found that BAF recruitment led to eviction of PRC1 and 2 within 2 minutes (Stanton et 
al. (NG-LE43713R, accepted). Addition of rapamycin resulted in robust recruitment of 
(Supplemental Fig. 2c). In contrast to the highly repressed Oct4 locus in MEFs, we were 
able to detect H3 turnover using CATCH-IT analysis43 and also depletion of H3 by CHIP 
(Supplemental Fig. 2c). Thus, it appears that polycomb eviction occurs without detectable 
H3 or H3K9me3 depletion at the facultative heterochromatin of the Oct4 locus of MEFs, but 
H3 exchange is clearly detectable in ES cells at the accessible Ascl1 locus upon BAF 
recruitment.
We predicted that if Polycomb contributed significantly to repression of the Oct4 locus we 
would find enhanced accessibility over the recruitment sites corresponding to either the 
removal of the H3K27me3 mark or of polycomb complexes. We assayed accessibility using 
a modified ATAC-seq assay which measures the ability of the Tn5 transposase to invade 
open, but not closed chromatin (Supplementary Fig. 2d,e)44. Remarkably, the development 
of accessibility as reflected by lag-times quickly followed the near maximum removal of 
H3K27me3 and H2Aub1 (Fig. 2e, Fig. 2b,c) Accessibility was restricted to the recruitment 
region of the locus and was not significantly altered at more distant regions (Supplementary 
Fig. 2e).
Our studies predict that BAF and PRC should colocalize over the genome. Indeed, we find 
that 67% of BAF sites are co-occupied by PRC1 genome-wide, strongly suggesting that 
these two complexes somehow cooperate (Supplementary Fig. 2f). This level of co-
occupancy is higher than PRC2 with PRC1, which are known to function synergistically5,38. 
In other studies, we have found that BAF directly binds PRC1, but not PRC2, and releases it 
in an ATP-dependent mechanism (Stanton et al, accepted (NG-LE43713R)).
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We were concerned that steric interference by recruitment of a large complex, several fold 
larger than PRC1 and 12-fold larger than a nucleosome could account for polycomb 
eviction. Thus, we recruited the LSH (HELLS) ATP-dependent chromatin remodeler. While 
addition of rapamycin effectively recruited these complexes to the Oct4 locus, we did not 
detect removal of PRC1 or the H2AK119ub1 repressive mark placed by this complex (Fig. 
2f), indicating that PRC eviction is a specific property of BAF complexes.
Finally, Oct4 gene expression (as assayed by GFP-positive cells and mRNA levels) was not 
induced (Supplementary Fig. 2g), likely due to the substantial, unaltered repression by 
H3K9me3 (Fig. 2d), DNA methylation and lack of recruitment of RNA Pol II 
(Supplementary Fig. 2h). Recent studies have demonstrated that loss of PRC2 repression 
only activates bivalent genes with the H3K4me3 mark45, explaining the absence of gene 
activation upon polycomb eviction. Thus our system allows one to deconvolute the effects of 
these influences on accessibility in the absence of other variables.
Repressed heterochromatin is reestablished following BAF removal
Genes active in early development such as Oct4 are often repressed by polycomb during the 
course of differentiation. To understand the underlying mechanisms, we studied the 
reassembly of polycomb-repressed heterochromatin. This was achieved using FK101234, a 
dimeric competitive inhibitor of rapamycin which binds only to the FKBP side and rapidly 
competes away rapamycin (Fig. 3a, Supplementary Fig. 3a). In comparing the kinetics of 
rapamycin washout (via media change) versus addition of FK1012, we determined that 
FK1012 resulted in more rapid, robust decreases in BAF complex tethering to the Oct4 locus 
(Fig. 3b), enabling us to determine if inaccessible heterochromatin could be reformed. We 
found that addition of FK1012 lead to the removal of BAF complexes within t=15’<t<30’ 
minutes (Fig. 3b), as assessed by anti-V5 ChIP, and the reappearance of PRC2 (Ezh2) and 
H3K27me3 by t=0.5<t<2.5 hours (Fig. 3c). We found that PRC2 (Ezh2) and PRC1 (Ring1b) 
began to reappear within ~2 hours post-addition of FK1012 and that this was paralleled by 
the reappearance of H3K27me3 and H2Aub1. (Fig. 3c,d). The open, DNA-accessible state 
produced by BAF complex dissociation was not stable, as suggested by in vitro studies on 
nucleosomal templates46, but rather, inaccessible chromatin began to reform within 2.5–5 
hours after removal of the BAF complex (Fig. 3e and Supplementary Fig. 3b–e). These 
washout experiments mimic the developmental transition that occurs over many genes that 
are active in early development and later become repressed by polycomb and facultative 
heterochromatin. Thus, our system allows one to make kinetic determinations in vivo of both 
dissolution and establishment of facultative heterochromatin.
Eviction of polycomb repressive complexes and associated histone marks is dependent 
on the ATP-ase activity of Brg1
The ATPase activity of BAF complexes provided by the Brg1 or Brm subunits is necessary 
for the function of BAF complexes in a variety of assays and the ATPase domains are 
frequently mutated in cancer and neurologic diseases39,47. Hence, we asked if the ATPase 
activity of Brg1 were necessary for PRC1 and PRC2 eviction. Thus, we directly recruited 
Brg1 by fusing the Frb tag on the C-terminus of the protein. This strategy did not give as 
robust recruitment of BAF as did the fusion on SS18. However, we did find that the Brg1 
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fusion gave about a 4- to 8-fold increase in occupancy of Baf155 at the recruitment site, as 
compared to SS18 fusion (40- to 60-fold). To test the role of the ATPase activity of Brg1, we 
used a mutation (K-to-R; K785R) with reduced ATPase activity48 found in a number of 
cancers and neurologic diseases47. Recruitment of this mutant Brg1 protein to the Oct4 locus 
of MEF (Fig. 4a,b) led to less PRC1 and PRC2 eviction than found with wild-type Brg1 
(Fig. 4c,d). Thus, the ATPase activity of Brg1 is required for this novel activity. This result, 
along with the LSH recruitment studies (Fig. 2f) rules out the possibility that non-specific 
steric occlusion contributes to PRC eviction. The experiments above indicate that BAF 
complexes are capable of driving a transition between inaccessible higher order chromatin 
structure toward accessibility, and that this is due to the direct eviction of both PRC2 and 
PRC1 complexes.
Recruitment of cancer-specific BAF complexes to repressed heterochromatin
BAF complexes can behave as either oncogenes or tumor suppressors. Unfortunately, it has 
not been possible to directly assay the effects of these mutations using in vitro assays. 
Hence, we asked if we would be able to discern the mechanism of these oncogenic 
mutations using the CIAO assay. To this end, we recruited BAF complexes with highly 
specific, driving subunit mutations, which define specific cancer subtypes to polycomb-
repressed chromatin. To study the consequences of recruitment of BAF complexes lacking 
the BAF47 (hSNF5) tumor suppressor subunit, the hallmark feature of pediatric malignant 
rhabdoid tumors (MRTs), we performed shRNA-mediated KD of BAF47 (KD efficiency 
>80%). We then recruited BAF complexes using BAF57 as the Frb-V5 tagged subunit in this 
case as BAF47 KD results in reduced SS18 binding into BAF complexes (unpublished 
results) (Fig. 5a, Fig. 1e, Supplementary Fig. 1d). Frb-V5-BAF57 tagged complexes, both 
wild-type and complexes lacking BAF47 displayed comparable recruitment levels to the 
Oct4 locus (Fig. 5b–c). Intriguingly however, BAF47-lacking complexes exhibited 
significantly decreased ability to displace Ezh2 (PRC2 complexes), Ring1b (PRC1 
complexes) and the H3K27me3 mark at the Zinc-finger binding domain, as compared to 
wild-type complexes (Fig. 5d–f). This demonstrates that BAF47 loss in these tumors leads to 
an inability to oppose polycomb, mechanistically explaining the tumor suppressive functions 
previously observed at the Ink4A locus and others21 and justifying the therapeutic use of 
PRC inhibitors.
BAF complexes can also be oncogenes that both initiate and drive cancer as is the case with 
the SS18-SSX translocation, which is found in nearly 100% of synovial sarcomas and in 
nearly 100% of the cells. Hence we determined if BAF complexes with the SS18-SSX 
fusion could oppose polycomb. To perform these studies, we developed Frb-V5-SS18-SSX 
fusions to be directly compared with our measurements using Frb-V5-SS18 (wild-type) (Fig. 
6a). Using anti-Brg1 immunoprecipitation, we demonstrated that these complexes bear the 
expected features of BAF complexes containing the SS18-SSX fusion as demonstrated 
previously23; namely, reduced protein assembly of BAF47 as well as wild-type SS18 (Fig. 
6b). Notably, as compared to WT SS18 containing BAF complexes, SS18-SSX BAF 
complexes displayed a dramatically extended domain of BAF occupancy, spreading 
2620±456bp (CI=95%) into the Oct4 gene body as compared to WT SS18 (920±305bp 
(CI=95%)), likely reflecting gained multimerization or processivity of complexes (Fig. 6c). 
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While BAF complex recruitment at the zinc-finger recruitment site (+0bp) was comparable 
for the WT SS18 and SS18-SSX fusion over a 60-minute time course (Supplementary Fig. 
4a), BAF complex occupancy at downstream sites >1000bp into the exon was achieved only 
by SS18-SSX oncogenic BAF complexes (Fig. 6c, Supplementary Fig. 4e). Importantly, 
SS18-SSX oncogenic BAF complexes robustly displaced both PRC2 and PRC1 complexes 
(Fig. 6d,e, Supplementary Fig. 4b–c,f–g), as well as the H3K27me3 repressive mark (Fig. 
6f, Supplementary Fig. 4d,h) at +1034 bp and +2287 bp sites from the ZFHD1 recruitment 
site, while WT SS18 complexes were unable to achieve these effects outside of the 
ZFHD1±500bp region of the recruitment site. These kinetic results explain the robust 
removal of PRC2 and H3K27me3 over the entire SOX2 gene in synovial sarcoma.
DISCUSSION
Our studies indicate that the mechanism by which BAF complexes oppose polycomb 
complexes is at least in part achieved through rapid eviction of PRC1 and PRC2 (Fig. 7). 
The ATPase activity of Brg1 is required for eviction, suggesting the specificity of the process 
and pointing toward possible mechanisms for ATPase-dead mutations in human cancers. The 
fact that eviction occurs within 2–5 minutes indicates that neither cell replication nor 
transcription is necessary for polycomb removal. This illustrates the power of the CiAO 
system, which enables precise temporal control over the kinetics of BAF-polycomb 
opposition. Because we could not detect the expected enhanced rates of nucleosome 
turnover for either H3K9me3 or H3, we speculate that the loss of H3K27me3 reflects the 
natural rates of decay due to histone demethylases and basal rates of nucleosome removal43. 
Indeed, BAF has been reported to bind to H3K27 demethylases 49 suggesting that it might 
recruit these enzymes to its sites of action. Accessibility rapidly follows the loss of 
H3K27me3 and H2Aub1, as expected from previous studies. In our CIAO system, we 
essentially convert the chromatin landscape of the Oct4 gene in MEFs to be more like that in 
ES cells, in which the gene is active and covered by a large domain of BAF. By removing 
the CIP by competition (FK1012), we revert the locus to one with inaccessible chromatin 
consistent with a continuous opposition between the two complexes rather than a stable 
expression state based on nucleosome structure.
The mechanism of action that we describe in which BAF prepares a polycomb repressed 
locus for binding of transcription factors (Fig. 7) provides an explanation for the apparent 
instructive functions of specific BAF complexes. For example, switching the subunit 
composition to the neural specific nBAF complex in human fibroblasts converts them to a 
basal neuronal state that can be biased with specific transcription factors to produce types of 
neurons that have never been produced in culture from either ES cells or fibroblasts50–52. 
Instructive roles have also been reported in IPS conversion53, the heart field54, the wiring of 
the drosophila olfactory system55 and induction of specific types of neurons in C.elegans56. 
The model (Fig. 7) does not reduce the need for sequence-specific or linage-specific 
transcription factors, but rather suggests that BAF and its tissue-specific assemblies act to 
open the range of possible binding sites for such factors and may possibly also aid in the 
positioning of nucleosomes to allow transcription factor binding.
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The SS18-SSX fusion protein, which both initiates and drives synovial sarcoma is an 
example of an instructive oncogenic function of an altered BAF complex23. Addition of only 
78 aa of SSX on to the C-terminus of the SS18 subunit leads to preferential assembly of the 
fusion protein into an oncogenic BAF complex that then targets the inactive Sox2 locus, 
removing polycomb and activating the expression of the Sox2 gene, which then drives 
proliferation. This sequence of events largely precludes a mechanism in which a 
transcription factor recruits BAF, because the Sox2 locus is inactive in the cell type that 
gives rise to malignancy and the oncogenic BAF complex can activate the Sox2 gene in 
fibroblasts, in which the Sox2 locus is inactive and likely not occupied by transcription 
factors (Fig. 7g). Our direct in vivo recruitment studies indicate that the role of the SS18-
SSX fusion is to produce a complex that propagates along the chromosome to occupy a 
larger region than is normally occupied by BAF over the Sox2 gene in cells in which it is 
inactive. We find this larger region of occupancy in both BAF ChIP-seq studies in the 
malignant synovial sarcoma cells that bear the translocation23 and also when we recruit the 
complex to the silent Oct4 locus of MEFs. The propagation of the complex leads to a larger 
domain of Polycomb removal and hence a greater chance that a transcription factor present 
in fibroblasts will bind to the now accessible chromatin prepared by the oncogenic BAF 
complex. This scenario nicely illustrates how these complexes can assume an instructive 
function (in this case uncontrolled proliferation) by allowing transcription factors present in 
fibroblasts to activate a gene normally only active in pluripotent cells and neural progenitors. 
In the same way the nBAF complex might prepare neural specific genes for activation during 
reprogramming of fibroblasts to neurons50,51. Our studies also indicate that the loss of the 
BAF47 (hSNF5) tumor suppressor subunit, in malignant rhabdoid tumors, leads to 
substantially diminished eviction (Fig. 7f). This mechanism nicely predicts the observations 
in malignant cells suggesting that loci that repress proliferation, such as Ink4a, become 
intensely repressed by a domain of H3K27me3 that builds over this gene leading to a failure 
to halt cell division21. Thus, our studies provide an explanation for both the tumor 
suppressor (BAF47 deletion in MRT) and oncogenic (SS18-SSX fusion in synovial sarcoma) 
functions of BAF complexes.
Recent exome sequencing studies have revealed striking frequencies of mutations in both 
BAF and polycomb subunits in human cancers39,57. Where studied, mutations in subunits of 
BAF complexes lead to altered polycomb domains over the genome that have essential 
functions in either oncogenesis or pluripotency12,21,23. However, we and others were faced 
with an inability to discern whether polycomb removal was direct or indirect, or whether 
replication or transcription were necessary for polycomb removal as commonly assumed. 
Our studies indicate that this widespread opposition is being constantly and directly waged 
and that its plasticity lends itself well to both developmental signaling and the balance 
between normal proliferation and tumor formation.
MATERIALS AND METHODS
Cells and Construct Design
CiA mouse embryonic fibroblasts (MEFs) containing a modified Oct4 promoter (with 12X 
ZFHD1 and 6X GAL4 sites upstream of the promoter) were generated, cultured and 
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maintained as previously described30. Briefly, lentiviral delivery constructs bearing an EF1-
alpha promoter and either puromycin or blasticidin resistance were generated to contain the 
constructs described here (Supplemental Fig. 1b). To generate recruitable forms of BAF 
complexes, genes encoding individual BAF complex subunits (SS18, BRG1, BAF47, 
BAF57) were fused in frame to sequences encoding Frb-V5. We generated the following 
constructs: Frb-V5-huSS18, Frb-V5-huSS18-SSX1, Frb-V5-huBAF57, and Frb-V5-
huBAF47, huBRG1-Frb-V5, huBRG1(K785R)-Frb-V5, and a control Frb-V5-STOP to be 
paired with co-infected ZFHD1-FKBP.
Recruitment Assays
Briefly, adherent CiA MEF cells were treated with 3nM (final concentration) rapamycin 
(sirolimus; Selleckchem #S1039) (ON experiments) or 3nM rapamycin followed by 30nM 
FK1012 (OFF/washout experiments) for prescribed times, as indicated (2.5 minutes- 24 
hours). For acute time points, cells were harvested rapidly by washing media out once with 
PBS, scraping cells off plates with a cell scraper and resuspending in cell fix buffer (50mM 
HEPES, 1mM EDTA, 0.5mM EGTA, and 100mM NaCl), and formaldehyde-based fixing 
for subsequent ChIP analyses.
Immunoblot analyses
BAF complex subunits modified with Frb-V5 tags were tested for expression and complex 
integration using standard nuclear protein extract purification and subsequent anti-BRG1 
immunoprecipitation from 150ug of nuclear extract input (anti-BRG1 (SCBT G7 clone; 
sc-17796)). Immunoblot analyses were performed using the antibodies indicated: BAF47 
(SCBT Clone A-5; sc-166165), BAF57 (Bethyl A300-810A), SS18 (SCBT Clone H80; 
sc-28698), V5 epitope tag antibody (Invitrogen; R960-25).
Chromatin Immunoprecipitation (ChIP)
Briefly, for rapid time course assays, adherent CiA MEF cells were washed once in PBS, 
scraped off plates into fix buffer (50mM HEPES, 1mM EDTA, 0.5mM EGTA, and 100mM 
NaCl), resuspended, and immediately formaldehyde fixed (for 10 minutes at room 
temperature). After quenching cross-linking using 0.125M (final) glycine, cells (7–10 
×10^6) were washed and sonicated for 13.5 minutes using a Covaris E220 Sonicator 
(Covaris, Inc., Woburn, MA). Chromatin input was reverse crosslinked, evaluated for 
shearing efficiency, and 100–150 ug of chromatin stock was used per immunoprecipitation 
reaction. Antibodies (3ug/ChIP reaction) used for ChIP (listed in Supplemental Table 1) 
were incubated with chromatin stock and Protein G Dynabeads (Cat# 1004D) overnight at 4 
degrees C. Following washing, immunoprecipitated material was eluted and subjected to 
reverse crosslinking. Finally, DNA precipitation was performed using phenol/chloroform 
extraction and ChIP DNA was reconstituted in 50ul TE for qPCR reactions. Primers used in 
ChIP assays are listed in Supplemental Table 2.
ChIP Analysis and Statistical Calculations
CiA knock-in locus-specific primers were generated and are reflected in Table Y with plus 
(+) and minus (-) direction distances calculated from the middle of the ZFHD1 recruitment 
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domain as well as minus (+/-) distances calculated from the Oct4 transcription start site 
(TSS). Briefly, enrichment (bound over input) values were normalized to values with no 
rapamycin treatment. Standard deviations were calculated over n=3 repeat experiments for 
each primer set. Student’s two samples unpaired t-test was performed to determine statistical 
significance.
Tn5 transposase Chromatin Accessibility Assays (ATAC-qPCR)
Following various recruitment conditions, 5×10^4 CiA Oct4 MEF cells were harvested, 
washed once in PBS, once in RSB buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM 
MgCl2), and centrifuged at 500×g for 5 minutes at 4 degrees C. Cells were then lysed in 
lysis buffer (500ul RSB buffer + 5ul 10% NP-40) for 5 minutes on ice, spun at 500×g for 5 
minutes, resuspended in Tagment DNA/Enzyme Buffer Mix (Illumina Nextera Sample 
Preparation Kit, Cat. # FC-121-1030), and incubated for 30 minutes at 37 degrees C. 
Following Tn5 transposase enzyme reaction, DNA was purified using Quiagen MinElute 
PCR Purification Kit (Cat # 28004). Transposed DNA fragments were amplified via qPCR 
to the appropriate number of cycles and library was purified using a Quiagen PCR Cleanup 
Kit eluted in 20ul of elution buffer (10mM Tris Buffer, pH 8.0). CiA locus-specific qPCR 
was performed using primers in Supplemental Table 2.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Design and development of a rapidly-inducible system to recruit BAF complexes to 
heterochromatin in vivo
(a) Recruitment schematic for Frb-tagged BAF complexes by rapamycin in MEFs to the 
Oct4 (Pou5f1) locus. Rapamycin (FK506) dimerizes Frb and FKBP. Primer distances are 
distances from Oct4 TSS. (b) Mouse embryos with recruitment system and CiA-modified 
Oct4 allele (GFP) exhibit normal embryonic development and similar Oct4 expression from 
the inserted allele and the wild-type allele in blastocysts. (c) ChIP-qPCR and ChIP-seq for 
repressive and activating marks indicates large-scale repression of the Oct4 locus. (Error 
bars = Mean ± SD for n=10 experiments). (d) Total nuclear input and anti-Brg1 
immunoprecipitation shows Frb-V5-Ss18 properly assembles into BAF complexes. (e) BAF 
complex recruitment (ChIP-qPCR fold enrichment over no rapamycin treatment at the 
ZFHD1 site (-443bp)) can be achieved using several different Frb-tagged BAF subunits. 
BAF complex recruitment reaches saturation by 1.5 hours. (f) Anti-Brg1, anti-Baf155 ChIP-
qPCR demonstrates that Frb-V5-Ss18 recruits the complete BAF complex to the ZHFD1 
recruitment site (-443bp). (g) Landscape plot of anti-V5 ChIP-qPCR data demonstrates BAF 
complex regional occupancy over a t= 0–60min time course. BAF domain spread is 
920±305bp from the ZFHD recruitment site (95% confidence interval). Error bars = Mean ± 
SD for n=3 experiments in (e-g).
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Figure 2. BAF complexes displace PcG repression upon recruitment
(a) Schematic for rapamycin-induced recruitment of Frb-V5-Ss18 BAF complexes. (b-c) 
BAF complex recruitment results in (b) Ezh2 displacement within 10 min followed by 
H3K27me3 removal within 20 min, and (c) Ring1b displacement within 5 min followed by 
H2AK119ub1 removal within 7.5min (at -443bp ZFHD1 site). (d) Total histone (H3) 
occupancy and non-PcG histone marks (H3K9me3, H2A.Z) are unaffected by BAF complex 
recruitment (left). Comparison of H3 levels to PcG marks shows removal of PRC1 
repression followed by removal of PRC2 repression, with H3 unchanged (right). (e) ATAC-
qPCR at ZFHD recruitment site (-443bp) shows increase in DNA accessibility upon BAF 
complex recruitment. (f) The HELLS (LSH) chromatin remodeler shows rapid recruitment 
via rapamycin-recruitment system (left), however PRC1 and PRC1-placed repressive marks 
are not displaced (right), nor are H3K9me3 or total H3. All ChIP-qPCR measurements are at 
the -443bp ZFHD1 site. Error bars = Mean ± SD for n=3 experiments except (c) for n=2 
experiments.
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Figure 3. Rapid removal of BAF complexes by competitive inhibition of rapamycin triggers 
reformation of repressed heterochromatin
(a) Schematic for FK1012-driven washout of rapamycin-tethered BAF complexes. (b) 
Comparison of BAF occupancy upon FK1012-driven washout to no washout (media 
exchange). (c-d) FK1012 washout triggers show reformation of heterochromatin, with (c) 
PRC2 and (d) PRC1 repression begining to reform within hours. (e) ATAC-qPCR at 
recruitment shows accessibility is lost upon FK1012 washout and reformation of 
heterochromatin. All ChIP-qPCR measurements are at the -443bp ZFHD1 site. Error bars = 
Mean ± SD for n=3 experiments.
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Figure 4. BAF complex-mediated eviction of Polycomb is ATP-dependent
(a) Brg1-V5-Frb system for rapidly recruiting BAF complexes containing wild-type Brg1 or 
ATPase-dead Brg1 (K785R mutant). (b) BAF complex recruitment to the ZHFD1 
recruitment site with wild-type and ATPase-dead Brg1 is comparable. (c-d) Eviction of PcG 
proteins is dependent on ATPase function, with (c) Ezh2 and (d) Ring1b eviction reduced 
with ATPase-dead Brg1 as compared to wild-type Brg1. All ChIP-qPCR measurements are 
at the -443bp ZFHD1 site. Error bars = Mean ± SD for n=3 experiments. (** p-value < 
0.01).
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Figure 5. Baf47-deficient (MRT-like) BAF complexes fail to evict PcG repression
(a) Frb-V5-Baf57 system for rapidly recruiting BAF complexes lacking Baf47. (b) Total 
nuclear input and anti-Brg1 in BAF complexes. (c) BAF complexes in shCtrl and shBaf47 
cells display comparable recruitment at ZHFD1 recruitment locus. (d-f) MRT-like BAF 
complexes (lacking Baf47) fail to evict PcG proteins at ZHFD1 recruitment site, with (d) 
Ezh2, (e) Ring1b, and (f) H3K27me3 evicted by wild-type BAF but not by MRT-like BAF. 
All ChIP-qPCR measurements are at the -443bp ZFHD1 site. Error bars = Mean ± SD for 
n=3 experiments. ( ** p-value < 0.01)
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Figure 6. SS18-SSX-containing (SS-like) BAF complexes exhibit enhanced occupancy and 
Polycomb eviction
(a) Schematic of Frb-V5-Ss18 (WT) versus Frb-V5-SS18-SSX1 fusion (SS-like) for 
comparison of wild-type versus oncogenic BAF complexes. (b) Nuclear extract input and 
anti-V5 immunoprecipitation in cells with tagged Ss18 or SS18-SSX1. (c) Landscape plot 
reflecting enhanced occupancy of SS18-SSX1-containing BAF complexes as compared to 
wild-type (Ss18) around ZHFD1 recruitment site, into the Oct4 gene body. (d-f) SS-like 
BAF complexes exhibit enhanced downstream (+2287bp) PcG eviction over the Oct4 gene 
body of Ezh2 (d), Ring1b (e), and H3K27me3 (f). All ChIP-qPCR measurements in (d-f) are 
at the +1716bp ZFHD1 site. Error bars = Mean ± SD for n=3 experiments. (*** p-value < 
0.001).
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Figure 7. Model for rapid BAF-PcG opposition in normal and oncogenic settings
(a) BAF complex recruitment via Frb-V5-SS18 system begins to displace PRC2 (Ezh2) and 
PRC1 (Ring1b) by 3 min after rapamycin treatment. (b) H2AK119ub1 marks are rapidly 
removed from histones, with removal complete after 8 min of rapamycin treatment. (c) 
H3K27me3 begins removal upon completion of H2AK119ub1 removal, with removal 
complete by 20 min. (d) DNA accessibility accelerates upon removal of H3K27me3, with 
90% maximum accessibility within 40 min. (e) Time-dependent representation of PcG 
eviction and accessibility gain with BAF recruitment. (f) Tumor suppressor Baf47-deficient 
BAF complexes fail to evict PRC2 and PRC1, resulting in heterochromatin and repression of 
key tumor suppressors, such as INK4A. (g) Oncogenic, gain-of-function SS18-SSX BAF 
complexes exhibit enhanced occupancy and robust eviction of PRC2 and PRC1, resulting in 
open chromatin and expression of oncogene SOX2.
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